Episode 15: Adding stereotactic radiotherapy to abiraterone acetate significantly delays disease progression in oligometastatic CRPC patients: the ARTO trial
This content is accessible exclusively to verified healthcare professionals.
If you are a registered user, please log in here.
If you do not yet have an account, please register here.
Thank you for your understanding.